Press "Enter" to skip to content

Apple Watch, Johnson & Johnson partner on study to reduce stroke risk


Can the Apple Watch and an app on your iPhone reduce the likelihood you’ll have a stroke? 

Apple and Johnson & Johnson have launched a voluntary randomized nationwide study to explore that question. The study is meant to determine whether the iPhone and Apple Watch, can accelerate the diagnosis of a leading cause of stroke.

That would be atrial fibrillation, or AFib, an irregular and often rapid heart rate that causes about 130,000 deaths and 750,000 hospitalizations each year in the U.S., Johnson & Johnson said. 

Up to 30% of cases go undiagnosed until life-threatening complications occur. Worldwide, about 33 million people have the condition. According to the U.S. Centers for Disease Control and Prevention, AFib, the most common sustained cardiac arrhythmia, results in 158,000 deaths and 454,000 hospitalizations each year.

You will be notified within the Apple-Johnson & Johnson study if you receive an irregular rhythm notification or AFib.

The Apple Watch Series 5, which costs $399 or more, as well as the Series 4 have an irregular heart rhythm notification feature and an FDA-cleared ECG app, both of which are designed to detect AFib.

Apple and Johnson & Johnson previously announced their collaboration in January.

Some study participants can earn $150 or more, based on a points system tied to the activities you are asked to complete, such as answering surveys or meeting other goals.



Source link

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *